Safety and Efficacy of Subretinal Transplantation of Clinical Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Retinitis Pigmentosa
Clinical trial NCT03944239 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03944239
- Sponsor
- Qi Zhou
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-19
- Primary completion
- 2026-12-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.